Clinical efficacy in the treatment of Paget’ s disease of the bone Aclasta was studied in male and female patients aged above 30 years with primarily mild to moderate Paget’ s disease of the bone (median serum alkaline phosphatase level 2.6– 3.0 times the upper limit of the age-specific normal reference range at the time of study entry) confirmed by radiographic evidence.